Oxford BioMedica - Announcements

News / Announcements 1999

Date	Article

21 Dec 1999	Oxford BioMedica Completes Acquisition of Novel Antibody Technology

16 Nov 1999	Oxford BioMedica Develops Vector System for Gene Transfer in Therapy for Neural Diseases

17 Aug 1999	Announcement of results for The 6 Months to 30 June 1999

26 Jul 1999	Oxford BioMedica Appoints Ex-Fisons And SmithKline Director To The Board

06 Jul 1999	Oxford BioMedica Links Up With Modex Therapeutics To Develop Diabetes Therapy

21 Jun 1999	Oxford BioMedica Announces Expansion of Interaction with Rhone Poulenc Rorer on LentivectorT Technology

10 Jun 1999	Oxford BioMedica Releases pre-Clinical Data on MetXia-P450, the Company's First Product to go into Clinical Trial

25 May 1999	Oxford BioMedica Presents New Data on Synthetic HIV as an AIDS Therapy

19 May 1999	Oxford BioMedica moves into Pacific Rim

23 Apr 1999	Oxford BioMedica projects presented at two international conferences

26 Mar 1999	Oxford BioMedica PLC ("the Company") Results of Rights Issue

03 Mar 1999	Oxford BioMedica ("the Company") Announcement of Rights Issue

03 Mar 1999	Oxford BioMedica Announces Preliminary Results for the Year Ended 31 December 1998

15 Feb 1999	Oxford BioMedica Appoints Ex-Vice President of Genetic Therapy Inc as Non-Executive Director

29 Jan 1999	Oxford BioMedica Announces Positive Preclinical Tumour Vaccine Data

11 Jan 1999	Oxford BioMedica Receives US Patent Allowance for Gene Expression Control Technology

2008

Archive

2007

2006

2005

2004

2003

2002

2001

2000

1999

1998

1997